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Abstract
Background: Liver stiffness measurement (LSM) using transient elastography has recently become available for the
assessment of liver fibrosis. Whether LSM can predict the functional liver reserve in patients undergoing liver resection is not
certain.
Aim: To correlate liver stiffness measurement (LSM) with indocyanine green (ICG) clearance test and liver biochemistry, and
to determine its usefulness in predicting postoperative outcomes in patients undergoing liver resection.
Patients and Methods: Transient elastography and ICG clearance test were performed pre-operatively in 44 patients with
hepatocellular carcinoma. The LSM and ICG retention rate at 15 minutes (R15) were correlated with pre-operative factors
and post-operative outcomes.
Results: There was significant correlation between ICG R15 and LSM. In patients with LSM $11 kPa vs ,11 kPa, there was
significantly higher ICG R15 (17.1% vs 10.0% respectively, p = 0.025). For patients with ICG R15$10% compared to those
,10%, there was significantly higher LSM (12.0 vs 7.6 kPa respectively, p = 0.015). Twenty-eight patients proceeded to
resection. There was a significant correlation between LSM and the peak INR after liver resection (r = 0.426, p = 0.024). There
was a significant correlation between ICG R15 and the post-operative peak AST level (r =20.414, p = 0.029) and peak ALT
level (r =20.568, p = 0.002). The operative time was a significant independent factor associated with post-operative
complications and peak INR.
Conclusion: LSM correlated well with ICG R15 in patients undergoing liver resection, and predicted early post-operative
complications. Addition of LSM to ICG R15 testing may provide better prognostic information for patients undergoing
resection.
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Background
Hepatocellular carcinoma (HCC) is the most common primary
tumour of the liver, and the fifth commonest malignancy
worldwide [1]. Under normal circumstances, hepatic resection is
well tolerated as the liver regenerates rapidly. However, in patients
with HCC, the remnant liver is often abnormal due to underlying
chronic liver disease. For patients with HCC, bridging fibrosis or
established cirrhosis is frequently observed in the non-tumour
tissue. It is therefore of paramount importance that the underlying
liver function is not severely compromised to cause decompensa-
tion and death after liver resection. Stringent pre-operative
assessment is therefore essential to prevent post- resection
morbidity and mortality. Routine liver biochemistry, the Child
Pugh classification, and the Model for End-stage Liver Disease
(MELD) score provides an estimation of the severity of liver
disease, but cannot predict the liver synthetic function reserve, or
the ability of the liver to regenerate after resection [2,3,4].
Indocyanine green (ICG) clearance test, a more objective
measurement for liver reserve is commonly adopted in many
centers because of its high predictive value for postoperative
outcome after liver resection [5]. ICG is a synthetic dye which
binds completely to albumin and b-lipoprotein and is eliminated
by the liver into the bile virtually unchanged without any
extrahepatic metabolism or excretion [6]. Excretion of ICG is
dependent on hepatic adenosine triphosphate concentration, and
decreased levels may reflect reduced ability to regenerate after
liver resection. The ICG retention value at 15 minutes (ICG R15)
after injection is approximately 10% in normal persons. A cut-off
value for a safe major hepatectomy is 14%, although the cut-off
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may be higher for centres with more operative experience, patients
with adequate remnant liver volume and/or with limited
resections [7,8]. Infrared digital measurement based on pulse
spectrophotometry can be used at bedside to replace repetitive
blood taking, and has been shown to be accurate in determining
blood ICG concentration [9,10,11].
Recently, liver stiffness measurement (LSM) by transient
elastography has become available for the non-invasive assessment
of liver fibrosis. LSM has been shown to correlate well with liver
biochemistry, liver histology, and predictive of long term outcome
in Asian patients with chronic hepatitis B [12,13,14]. In patients
with established cirrhosis, higher LSM may also predict compli-
cations of cirrhosis including the presence of varices and the
development of HCC [15,16]. A pilot study also demonstrated
that LSM may be useful in predicting development of postoper-
ative hepatic insufficiency after resection for HCC [17]. Therefore,
LSM may be able to predict the functional liver reserve indirectly
through the assessment of fibrosis level.
The current study aims to correlate LSM with ICG clearance
test and routine liver biochemistry, and to determine its usefulness
in predicting postoperative outcomes in patients with HCC
undergoing liver resection.
Patients and Methods
Patients with HCC scheduled for potential liver resection from
October 2010 to December 2011 at Queen Mary Hospital, Hong
Kong, were prospectively recruited. All patients enrolled in the
study underwent ICG clearance testing (Pulsion Medical Systems
AG, Munich, Germany) and LSM using transient elastography
(Echosens, Paris, France) on the same day. Routine liver
biochemistry was performed. Basic patient demographics and
operation details were recorded. Pre- and post-operative labora-
tory results and outcome were monitored. Written informed
consent was obtained from all subjects. This study was approved
by the Ethics Committee/Institutional Review Board of the
University of Hong Kong and Hospital Authority Western
Cluster. All clinical investigations were conducted according to
the principles expressed in the Declaration of Helsinki.
ICG Clearance Test
The ICG clearance test was performed with the patient fasted
for 6 hours. ICG was administered intravenously at a dose of
0.5 mg/kg. The ICG Plasma Disappearance Rate (PDR) was
measured transcutaneously using a near-infrared finger clip sensor.
The ICG retention rate at 15 minutes (R15) was then calculated.
The ICG retention value at 15 minutes (ICG R15) after injection
is approximately 10% in normal persons, and this value was used
for stratification of patients in the current study [18].
Liver Stiffness Measurement
This procedure has been well described previously [12]. The
LSM was performed by a single experienced operator (who had
performed over 2000 scans). The operator was blinded of the ICG
results of the patients. At least 10 valid measurements were
obtained for each patient. The median values of the validated
measurements for each patient were representative of the liver
stiffness and expressed in units of kilopascals (kPa). The results
were valid only for the final analysis if the success rate was greater
than 50% and the interquartile range (IQR)-to-liver stiffness ratio
was below 30%. A cut-off value of 11 kPa has been shown to be
predictive of the presence of cirrhosis, and this was used for
stratification in the current study [19].
Statistical Analyses
All statistical analyses were performed using SPSS version 17.0
(SPSS Inc, Chicago, IL). Chi-squared test or Fisher’s exact test was
used for categorical variables when appropriate. Continuous
variables with skewed distribution were analyzed using Mann-
Whitney test. The comparison of different median values of more
than two groups was made by Kruskal-Wallis test. The correlation
co-efficient was calculated using Spearman test. Multivariate
analysis was performed using linear regression. The area under
receiver operating characteristic (AUROC) curve was used to
derive an optimal cut-off of liver stiffness measurement for
predicting short-term complications after liver resection. A p-
value of,0.05 was considered statistically significant.
Results
A total of 68 patients were enrolled during the recruitment
period in the current study. Twenty four were excluded from the
final analysis due to suboptimal (22 patients had high IQR/LSM
ratio) or invalid LSM (2 patients had less than 10 valid
measurements). Forty-four patients were included in the final
analysis. Thirty six (82%) were male. The median age was 59 years
(range, 46–75). The basic patient demographics and laboratory
data are summarized in table 1. The correlation between ICG
clearance and LSM with age and other routine laboratory
parameters are summarized in table 2. There were significant
correlations between ICG R15 and LSM, bilirubin, albumin,
international normalized ratio (INR), platelet levels, and MELD
scores, and between LSM and AST, albumin, INR, and MELD
scores. A previous study of CHB patients identified a LSM cut-off
value of 11 kPa for the presence of cirrhosis [19]. In our patients
with LSM $11 kPa vs ,11 kPa, there was significantly higher
ICG R15 (17.1% vs 10.0% respectively, p = 0.025), lower albumin
(38 vs 45 g/L respectively, p,0.001), higher INR (1.1 vs 1.0
respectively, p,0.001), and lower platelet counts (131 vs
1706109/L respectively, p = 0.043). The normal ICG R15 is
,10% [18]. For patients with ICG R15$10% compared to those
,10%, there was significantly higher LSM (12.0 vs 7.6 kPa
respectively, p = 0.015), higher bilirubin (12 vs 8 umol/L respec-
tively, p = 0.039), lower albumin (41 vs 46 g/L respectively,
p,0.001), higher INR (1.1 vs 1.0 respectively, p,0.001), and
lower platelet counts (132 vs 1786109/L respectively, p = 0.027).
The comparison between LSM and ICG R15 is shown in figure 1.
Using multivariate analysis, only albumin remained a significant
factor associated with both ICG R15 and LSM (p= 0.011 and
p= 0.007 respectively).
Figure 1. Comparison between LSM and ICG R15.
doi:10.1371/journal.pone.0072306.g001
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Post-operative Outcomes
Of the 44 patients with valid LSM, 28 proceeded to liver
resection. The remaining 16 patients underwent one of the
following treatments: loco-ablative therapy, chemotherapy, or
palliation. Of the 28 patients who underwent resection, 10 had
segmentectomy, 4 had sectionectomy, 5 had wedge resection, and
9 had lobectomy. The characteristics of the resected patients are
shown in table 3. The correlations between operative and post-
operative parameters with pre-operative parameters are shown in
table 4. There was significant correlation between operative blood
loss and HCC size (r = 0.632, p,0.001) and operative time
(r = 0.510, p = 0.006), and between operative time and HCC size
(r = 0.573, p = 0.001).
Correlation with LSM
There was a significant correlation between LSM and the peak
INR after liver resection (r = 0.426, p = 0.024). No significant
correlation was observed between LSM and peak levels of
bilirubin, AST, and ALT, and length of hospital stay after
resection (table 4). In patients with LSM .11.0 kPa, a larger
HCC, greater blood loss, and a higher peak INR after resection
Table 1. Basic patient demographics and laboratory data.
Parameter Value
Total patients (N) 68
Invalid fibroscan 24
Numbers in final analysis (n) 44
Male sex, n(%) 36 (82%)
Age (years) 59 (46–75)
Bilirubin (umol/L) 9 (5–29)
ALT (U/L) 39 (16–167)
AST (U/L) 47 (21–263)
Albumin (g/L) 42 (26–52)
Creatinine (umol/L) 80 (57–485)
INR 1.0 (0.9–1.2)
AFP (ng/ml) 37 (3–539700)
Plalelet (x109/L) 155 (23–466)
MELD score 7.3 (6.4–13.7)
HCC size (cm) 3.5 (1–14)
Liver stiffness (kPa) 10.2 (3.3–75.0)
ICG R15 (%) 11.8 (5.9–40.7)
Continuous variables are expressed as median values (range).
doi:10.1371/journal.pone.0072306.t001
Table 2. Correlation between LSM, ICG R15 and other laboratory parameters.
Parameters Liver stiffness r co-efficient Liver stiffness P value ICG R15 r co-efficient ICG R15 P value
Liver stiffness – – 0.342 0.023
ICG R15 0.342 0.023 – –
Age 20.032 0.836 0.100 0.517
Bilirubin 0.136 0.378 0.349 0.020
ALT 0.228 0.137 2.080 0.605
AST 0.455 0.002 0.095 0.541
Albumin 2.0710 ,0.001 20.525 ,0.001
Creatinine 0.071 0.649 0.141 0.361
INR 0.682 ,0.001 0.548 ,0.001
AFP 0.140 0.369 0.081 0.605
Platelet count 20.176 0.253 20.322 0.033
MELD score 0.431 0.003 0.519 ,0.001
HCC size 0.248 0.108 20.211 0.174
doi:10.1371/journal.pone.0072306.t002
Table 3. Characteristics of patients undergoing liver
resection.
Parameters Value
Number of resected patients 28
Presence of cirrhosis 19 (68%)
Child Pugh Class (A:B:C) 27: 1:0
MELD score 7.2 (6.4–11.7)
Number of tumours 1 (1–6)
Size of largest HCC (cm) 4.2 (2–14)
Hepatitis B 23 (82%)
Hepatitis C 2 (7%)
Cryotpgenic cirrhosis 2 (7%)
Gastrointestinal stromal tumour 1 (4%)
Segmentectomy 18
Sectionectomy 4
Wedge resection 5
Lobectomy 9
Operation time (minutes) 343 (45–1149)
Blood loss (mls) 517 (50–2000)
Bilirubin (umol/L) 33 (18–79)
AST (U/L) 344 (66–3000)
ALT (U/L) 312 (39–3000)
INR 1.4 (1–2.3)
Length of hospital stay (days) 6 (3–21)
Continuous variables are expressed as median values (range).
doi:10.1371/journal.pone.0072306.t003
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was observed. The comparison between pre-operative LSM and
post-resection INR is shown in figure 2. No significant difference
was observed with respect to operative time, peak levels of
bilirubin, AST, and ALT after resection, and length of hospital
stay.
Apart from LSM, other parameters significantly correlated with
peak post-operative INR included pre-op AST (r = 0.424,
p = 0.025), HCC size (r = 0.605, p,0.001), and operative time
(r = 0.768, p,0.001). Using multivariate analysis, only the
operative time remained significantly associated with the peak
INR.
Correlation with ICG R15
There was a significant correlation between ICG R15 and the
post-operative peak AST level (r =20.414, p = 0.029) and peak
ALT level (r =20.568, p = 0.002). There was no correlation
between ICG R15 and post-operative peak bilirubin and INR
levels, and length of hospital stay (table 4). In patients with ICG
R15$10%, vs ,10%, there was a significant lower peak levels of
AST (294 vs 521 U/L respectively, p= 0.047) and ALT (154 vs
481 U/L respectively, p= 0.011) after resection (as shown in
figure 3). There was no significant difference with HCC size,
amount of operative blood loss, length of operative time, length of
hospital stay, and peak level of bilirubin and INR.
In addition to ICG R15, other factors that was significantly
correlated with peak AST included pre-operative platelet levels
(r = 0.379, p= 0.047) and operative time (r = 0.506, p= 0.006). For
peak ALT, other factors with significant correlations included pre-
operative bilirubin (r =20.419, p= 0.027), pre-operative albumin
(0.479, p= 0.010), pre-operative INR (r =20.426, p = 0.024), pre-
operative platelet count (r20.412, p= 0.030), and operative time
(r = 0.505, p = 0.006). Using multivariate analysis, only the
operative time remains significantly associated with both peak
AST and ALT levels after resection.
Of the 28 patients, 9 had hepatic inflow occlusion intra-
operatively, and there was no significant differences when
compared to the 19 patients without occlusion with respect to
peak AST (437 vs 284 U/L respectively, p= 0.156) and ALT (344
vs 154 U/L respectively, p = 0.085).
Presence of Cirrhosis
In patients who underwent liver resection, the surrounding non-
tumour tissue was assessed histologically for the presence of
cirrhosis. Of the 28 patients, 19 had evidence of established
cirrhosis on histology. In cirrhotic patients versus non-cirrhotic
patients, there was significantly higher LSM (9.9 vs 6.3 kPa
respectively, p = 0.012). There was no difference between cirrhotic
patients vs non-cirrhotic patients with respect to ICG R15 (14.6 vs
10.0% respectively, p = 0.498). There were no significant differ-
ences between cirrhotic and non-cirrhotic patients with respect to
Figure 2. Pre-operative liver stiffness associated with higher
post-resection INR.
doi:10.1371/journal.pone.0072306.g002
Table 4. Correlation between pre- and post- operative parameters.
Parameters Peak Br P value Peak ALT P value Peak AST P value Peak INR P value
Hospital
Stay P value
Pre-operative
Age 20.200 0.308 20.116 0.556 20.091 0.646 20.087 0.659 0.037 0.851
MELD score 0.165 0.402 20.252 0.196 20.219 0.264 0.126 0.524 20.029 0.882
AFP 0.447 0.019 20.161 0.423 0.033 0.871 20.064 0.753 20.179 0.372
HCC size 0.176 0.369 0.359 0.060 0.369 0.053 0.605 0.001 0.615 0.001
ICG R15 20.015 0.939 20.568 0.002 20.414 0.029 20.169 0.390 20.048 0.808
LSM 0.274 0.158 20.272 0.161 20.132 0.504 0.426 0.024 0.185 0.345
Operative
Operation time 0.026 0.895 0.505 0.006 0.506 0.006 0.768 ,0.001 0.619 ,0.001
Blood loss 0.169 0.391 0.261 0.179 0.334 0.082 0.659 ,0.001 0.412 0.029
doi:10.1371/journal.pone.0072306.t004
Figure 3. Pre-operative ICG R15 associated with higher post-
operative transaminases.
doi:10.1371/journal.pone.0072306.g003
Liver Stiffness & ICG in Liver Resection
PLOS ONE | www.plosone.org 4 August 2013 | Volume 8 | Issue 8 | e72306
the operative time, amount of blood loss, and peak levels of post-
operative bilirubin, AST, ALT, and INR.
Short-term Outcome
Of the 28 patients undergoing resection, all were discharged
well with a median hospital stay of 6 days (range, 3–21). We
defined post-operative complications as any deviation from the
normal recovery course with or without the need for pharmaco-
logical treatment or surgical, endoscopic, and radiological
interventions. Seven patients had evidence of early (,1 month)
post-operative complications, with a median time from operation
to development of complication of 11 days (range, 2–17). Ascites
developed in 4 patients and was the most common complication.
The remaining 3 complications included a combination of wound
leakage and pneumonia. The only factor significantly associated
with the development of complications was the operative time
(p = 0.008). Age, ICG, LSM, albumin, platelet, MELD score, the
presence of cirrhosis, HCC size and operative blood loss were not
significantly associated with the development of complications.The
HCC size, LSM, intra-operative blood loss, and operative time
were significantly associated with the post-operative peak INR.
After multivariate analysis, only the operative time remained the
only significant factor (p = 0.002), whereas ICG, LSM, albumin,
platelet count, MELD score, presence of cirrhosis, HCC size and
intra-operative blood loss were not significant factors.
Discussion
For patients undergoing liver resection, assessment of the liver
function is essential to ensure that sufficient liver function remains
after resection to allow for regeneration of the remnant liver and to
prevent decompensation and death. Current methods to assess
liver function include using the Child Pugh score, MELD score,
and the ICG R15. Routine laboratory, endoscopic and radiolog-
ical assessment can also be used to determine the presence of
underlying portal hypertension. More recently, transient elasto-
graphy has become available as a non-invasive method for
assessing liver fibrosis and cirrhosis. Previous studies have shown
good correlation between LSM and the degree of fibrosis
[12,13,14]. In patients with established cirrhosis, higher LSM
was also correlated with complications of cirrhosis, including the
presence of varices [13,15,16].
In contrast to LSM, ICG testing determines the functional
capacity rather than the degree of architectural change in the liver.
Although ICG is extracted exclusively by the liver with negligible
extrahepatic elimination, the clearance rate is dependent on
hepatic blood flow and plasma volume. Therefore, it remains an
imperfect test for assessing hepatic functional reserve. A previous
pilot study has suggested a potential role for LSM to predict post-
resection hepatic insufficiency [17]. A more recent study
demonstrated that elevated LSM was an independent predictor
of postoperative liver failure; those with LSM ,14.8 kPa had no
liver failure [20]. Another study showed that LSM .12.0 kPa
predicted worst outcomes after hepatectomy, and was better than
ICG test in predicting major postoperative complications [21].
In the current study, significant correlation between ICG R15
and LSM was demonstrated in patients undergoing liver resection.
However, after multivariate analysis, only albumin remained a
significant factor that was correlated with either ICG R15 or LSM.
This would suggest that the correlation between ICG R15 and
LSM is not independent of other more important factors such as
the level of serum albumin. This is not surprising given that ICG
R15 is a functional test whereas LSM is a structural assessment. In
fact, in patients with cirrhosis, the LSM was significantly higher
than non-cirrhotic patients, in comparison to ICG R15 where no
differences were observed.
There was also significant correlation of LSM and ICG R15
with post-operative outcomes. Interestingly, the post-operative
peak INR was correlated with LSM whereas the post-operative
peak AST and ALT were inversely correlated with ICG R15. The
higher INR observed is consistent with the fact that those patients
with higher LSM have more advanced fibrosis/cirrhosis, resulting
in a higher INR after resection. This implies that the risk of liver
decompensation may be higher in patients with high LSM who
undergo liver resection. This may be an important consideration
for those who have major liver resection. It will be interesting to
define in future studies, the role of LSM to stratify post-operative
risks in patients with different extent of liver resection.
Elevation of transaminases is commonly observed after liver
resection. The causes are multifactorial, including the duration of
operation, transaction surface and any ischemic injury to the liver
during operation. In the current study, only the length of
operation remains significantly associated with the post-resection
peak INR and transaminase after multivariate analysis. However,
it should be noted that the results of the multivariate analysis may
be affected by the relatively small number of patients (n = 28) who
eventually underwent liver resection. Further studies are required
to examine specifically whether LSM and ICG R15 are important
measurement to correlate liver decompensation and hepatocyte
damage respectively after liver resection.
There are several limitations to the current study. Firstly, there
was an unusually high rate of invalid FS (35%), so the number
included in the final analysis was reduced. This is most likely due
to the higher IQR that is often observed in patients with
established cirrhosis. In fact, only 2 of the patients excluded
because of invalid LSM were due to insufficient success rate.
Secondly, the patients included in the study have already been
selected as potential candidate for resection based on their normal
clinical parameters and the absence of overt portal hypertension.
To determine a cut-off value of ICG R15 and LSM whereby
resection is contra-indicated would require a proportion of
patients who decompensated after resection. As all 28 patients
were discharged without evidence of severe decompensation, this
would suggest that at least in pre-selected patients with compen-
sated cirrhosis and without evidence of portal hypertension, the
addition of LSM may not provide further decisional value in
addition to ICG R15. However, it is noteworthy that the majority
of patients underwent minor resection rather than lobectomy.
LSM may still have a role in assessing the risk of decompensation
in patients undergoing major hepatectomy and this needs a further
study to clarify.
In conclusion, LSM correlated well with ICG R15 in patients
undergoing liver resection, and may predict complications in the
early post-operative phase. Further studies are required to
determine whether the addition of LSM to ICG R15 testing has
any added benefit in the pre-operative assessment to select out
patients suitable for hepatectomy.
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